EICHOR
● Recruiting
A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
Condition: Alagille Syndrome · Sponsor: Ipsen
About this study
This study will collect information from patients with ALGS who are using odevixibat in their daily lives. Odevixibat is a medication that helps patients with ALGS, a rare disease that affects the liver and causes itching. The main aim of this study is to observe the long-term, everyday safety of the drug odevixibat in patients with ALGS who are receiving ongoing treatment.
This description comes directly from the study's public registry record.
Talk to the study team
Ipsen Clinical Study Enquiries · See e mail · clinical.trials@ipsen.com
Always discuss trial participation with your own doctor first.
Locations (14)
| Hospices Civils de Lyon - Hopital Femme Mere Enfant | Bron, France | Not Yet Recruiting |
| CHU Dijon Bourgogne | Dijon, France | Not Yet Recruiting |
| APHP - Hopital Bicetre - Paris Sud | Le Kremlin-Bicêtre, France | Not Yet Recruiting |
| APHM - CHU Timone | Marseille, France | Not Yet Recruiting |
| CHU de Montpellier - Hopital Saint Eloi | Montpellier, France | Not Yet Recruiting |
| APHP - Hopital Necker-Enfants Malades | Paris, France | Not Yet Recruiting |
| CHU de Toulouse - Hopital Paule de Viguier | Toulouse, France | Not Yet Recruiting |
| APHP - Centre Hepato-Biliaire Hospital Paul Brousse | Villejuif, France | Not Yet Recruiting |
| Azienda Ospedaliero Universitaria Meyer | Florence, Italy | Recruiting |
| Azienda Ospedaliera Di Rilievo Nazionale Santobono Pausilipon | Naples, Italy | Not Yet Recruiting |
| University Hospital Of Padova | Padova, Italy | Not Yet Recruiting |
| IRCCS Ospedale Pediatrico Bambino Gesu | Roma, Italy | Not Yet Recruiting |
+ 2 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07585097